PDS Biotechnology Corp Operating Leases, Future Minimum Payments, Due in Three Years
PDS Biotechnology Corp (PDSB) had Operating Leases, Future Minimum Payments, Due in Three Years of $530.38 thousand as of 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-02-21
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $530.38K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $603.37K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $603.37K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $603.37K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $530.38K 10-K · filed 2019-02-21 |
| 2018-09-30 | $603.37K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $603.37K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $603.37K 10-Q · filed 2018-05-01 |
| 2017-12-31 | $603.37K 10-K · filed 2018-03-01 |
| 2017-09-30 | $604.54K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $604.54K 10-Q · filed 2017-08-01 |
| 2017-03-31 | $604.54K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $604.54K 10-K · filed 2017-03-02 |
| 2016-09-30 | $602.46K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $583.38K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $583.38K 10-Q · filed 2016-05-03 |
| 2015-12-31 | $236.31K 10-K · filed 2016-03-08 |
| 2015-09-30 | $232.22K 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |